# Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

> **NCT02151773** · — · COMPLETED · sponsor: **Takeda** · enrollment: 3493 (actual)

## Conditions studied

- Measles/Rubella

## Interventions

- **DRUG:** Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain)

## Key facts

- **NCT ID:** NCT02151773
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 3493 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151773, "Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02151773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*